Doctors reviewed data from nearly 1,900 people with a common form of lung cancer. These patients received a mix of drugs that block immune checkpoints and standard chemotherapy before their planned surgery. The goal was to shrink tumors so surgeons could remove them completely.
Results showed that about three quarters of patients were able to have the surgery. In fact, every single patient in the study group had a clean operation where all visible cancer was removed. This is a very important step toward a better cure.
Looking inside the removed tissue, doctors found that about 36% of patients had no cancer cells left at all. Another 25% had a major reduction in cancer cells. Together, these good outcomes happened in over 60% of cases. Most side effects were mild and did not stop patients from finishing their treatment.
Because there was no direct comparison group in this review, doctors cannot say for sure if this treatment is better than other options yet. However, these results give strong reasons to start more formal tests to see if this approach truly helps patients live longer.